Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study
- PMID: 18334826
- DOI: 10.1159/000120023
Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study
Abstract
Objective: To determine the incidence and prevalence of amyotrophic lateral sclerosis (ALS) in the Republic of Uruguay.
Methods: The study was performed in Uruguay (3,241,003 inhabitants) during a 2-year period (2002-2003). To ensure complete case ascertainment, multiple sources of information were used, including all the neurologists, other medical specialties, general physicians, neurophysiology laboratories, hospital medical records and death certificates. ALS diagnosis was based on El Escorial criteria. Although all patients with motor neuron disease were enrolled in the follow-up, only probable and definite cases are included in the study.
Results: Between January 1st, 2002, and December 31st, 2003, 89 new patients were diagnosed with probable or definite ALS. The mean annual incidence rate was 1.37 per 100,000 persons. The incidence was higher for men (1.95) than for women (0.84) with a male to female ratio of 2:1. For both, the incidence increased throughout the years showing a peak in the 65-74 age group among men and the 55-64 age group among women. Mean age at onset of ALS disease was 58.7 years. The estimated mean annual incidence for ALS calculated by the capture recapture method was 1.42 (95% CI, 1.13-1.72). On December 31st, 2002, the crude prevalence was 1.9 per 100,000 inhabitants.
Conclusions: ALS incidence is within a narrow range across countries despite the genetic, environmental and socioeconomic differences when similar prospective design, diagnosis criteria and data analyses are applied.
2008 S. Karger AG, Basel
Similar articles
-
Epidemiology of ALS in Italy: a 10-year prospective population-based study.Neurology. 2009 Feb 24;72(8):725-31. doi: 10.1212/01.wnl.0000343008.26874.d1. Neurology. 2009. PMID: 19237701
-
Incidence of ALS in Lombardy, Italy.Neurology. 2007 Jan 9;68(2):141-5. doi: 10.1212/01.wnl.0000250339.14392.bb. Neurology. 2007. PMID: 17210896
-
[Changes in the incidence and clinical features of ALS in the Koza, Kozagawa, and Kushimoto area of the Kii Peninsula--from the 1960s to the 2000s (follow-up study)].Brain Nerve. 2010 Jan;62(1):72-80. Brain Nerve. 2010. PMID: 20112794 Japanese.
-
Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.Rheumatology (Oxford). 2006 Feb;45(2):187-91. doi: 10.1093/rheumatology/kei107. Epub 2005 Dec 6. Rheumatology (Oxford). 2006. PMID: 16332955 Review.
-
[Clinical course and epidemiological analysis of amyotrophic lateral sclerosis in Szczecin in 1986-1995].Neurol Neurochir Pol. 1999 Jan-Feb;33(1):71-8. Neurol Neurochir Pol. 1999. PMID: 10399726 Review. Polish.
Cited by
-
Risk factors for amyotrophic lateral sclerosis.Clin Epidemiol. 2015 Feb 12;7:181-93. doi: 10.2147/CLEP.S37505. eCollection 2015. Clin Epidemiol. 2015. PMID: 25709501 Free PMC article. Review.
-
Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.Eur J Epidemiol. 2016 Mar;31(3):229-45. doi: 10.1007/s10654-015-0090-x. Epub 2015 Oct 12. Eur J Epidemiol. 2016. PMID: 26458931 Review.
-
Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis.Nat Rev Neurol. 2024 Aug;20(8):475-494. doi: 10.1038/s41582-024-00991-7. Epub 2024 Jul 4. Nat Rev Neurol. 2024. PMID: 38965379 Review.
-
Projected increase in amyotrophic lateral sclerosis from 2015 to 2040.Nat Commun. 2016 Aug 11;7:12408. doi: 10.1038/ncomms12408. Nat Commun. 2016. PMID: 27510634 Free PMC article.
-
Immunological aspects in amyotrophic lateral sclerosis.Transl Stroke Res. 2012 Sep;3(3):331-40. doi: 10.1007/s12975-012-0177-6. Epub 2012 May 3. Transl Stroke Res. 2012. PMID: 24323808
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous